Squibb divestiture
Executive Summary
Firm says sale of its U.S. animal health div. to Solvay will result in after tax gain of approximately $12 mil. Squibb says divestiture "conforms with the company's strategic plan to focus on product areas where we can attain competitive advantage through basic research." The firm's animal health business outside the U.S. will not be affected.